Verona Pharma (VRNA)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

41.55

0.34%

After-hours Dec 13, 2024, 05:48 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05
Revenue	-	458.00K	40.00M	-	2.35K	2.78K	1.84M	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	679.62K	346.00K	-	627.85K	512.11K	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-679.62K	112.00K	40.00M	-627.85K	-509.76K	2.78K	1.84M	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-67.83M	-66.12M	-73.31M	-74.28M	-53.87M	-32.47M	-40.21M	-8.66M	-13.29M	-5.90M	-4.64M	-4.18M	-2.87M	-2.93M	-2.60M	-2.17M	-2.61M	-1.31M	-12.04K
Interest Income	12.81M	2.82M	14.00K	121.00K	988.62K	1.09M	466.24K	106.78K	66.36K	46.66K	4.34K	32.61K	6.21K	12.35K	11.32K	203.55K	192.36K	123.43K	56.78K
Pretax Income	-55.21M	-68.45M	-55.59M	-65.00M	-51.41M	-30.62M	-34.06M	-7.37M	-13.22M	-5.86M	-4.64M	-4.15M	-2.86M	-2.91M	-2.59M	-1.97M	-2.41M	-1.19M	44.74K
Net Income	-54.37M	-68.70M	-55.57M	-65.15M	-41.88M	-25.25M	-27.70M	-6.19M	-10.99M	-4.29M	-4.16M	-4.07M	-2.67M	-2.92M	-2.59M	-2.01M	-2.41M	-1.19M	44.74K
Selling & General & Admin	49.87M	26.58M	33.91M	29.77M	8.99M	7.99M	8.10M	2.89M	2.51M	1.80M	1.91M	1.47M	1.12M	1.09M	1.05M	827.39K	894.40K	1.05M	18.93K
Research & Development	17.28M	49.28M	79.41M	44.51M	43.89M	24.48M	32.05M	5.58M	10.76M	4.10M	2.73M	2.71M	1.46M	1.78M	1.53M	1.29M	1.50M	266.45K	-
Other Expenses	-	-9.63M	-15.63M	-8.27M	527.09K	16.50K	23.00K	1.07M	1.17M	-	-	0.00	268.60K	43.22K	11.32K	61.51K	196.33K	-	-113.57K
Operating Expenses	67.15M	66.23M	97.68M	66.01M	53.41M	32.48M	40.16M	8.49M	13.29M	5.90M	4.64M	4.18M	2.87M	2.93M	2.60M	2.17M	2.61M	1.31M	12.04K
Interest Expense	2.06M	521.00K	340.00K	35.00K	221.59K	-	98.65K	104.52K	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing Expenses	-	19.38M	22.24M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	67.83M	66.57M	97.68M	66.01M	53.41M	32.48M	40.16M	8.49M	13.29M	5.90M	4.64M	4.18M	2.87M	2.93M	2.60M	2.17M	2.61M	1.31M	12.04K
Income Tax	-632.44K	253.00K	-18.00K	146.00K	-9.53M	-5.37M	-6.36M	-1.18M	-2.24M	-1.56M	-477.22K	-77.68K	-192.52K	7.72K	-24.25K	41.00K	192.36K	123.43K	-
Shares Outstanding (Basic)	79.27M	66.13M	59.15M	32.87M	13.17M	131.39M	109.69M	2.09B	1.26B	1.08B	426.96M	383.28M	304.31M	298.45M	269.43M	261.38M	180.51M	96.58M	55.94M
Shares Outstanding (Diluted)	79.27M	66.13M	59.15M	32.87M	13.17M	131.39M	109.69M	2.09B	1.26B	1.08B	426.96M	383.28M	304.31M	298.45M	269.43M	261.38M	180.51M	96.58M	68.26M
EPS (Basic)	-0.54	-1.04	-0.94	-1.98	-3.18	-0.19	-0.25	-0.00	-0.01	-0.00	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	0.00
EPS (Diluted)	-0.54	-1.04	-0.94	-1.98	-3.18	-0.19	-0.25	-0.00	-0.01	-0.00	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	0.00
EBITDA	-52.47M	-67.29M	-42.19M	-47.81M	-32.17M	-25.50M	-29.64M	-6.96M	-8.92M	-3.74M	-2.78M	-2.56M	-2.86M	-2.88M	-2.59M	-1.94M	-2.39M	-1.19M	-12.04K
Depreciation & Amortization	679.62K	636.00K	629.00K	627.85K	512.11K	124.35K	166.22K	76.03K	78.69K	82.43K	61.99K	49.08K	37.26K	32.41K	35.57K	27.82K	27.76K	3.92K	-